BlackRock Health Sciences Trust (NYSE:BME) Plans Monthly Dividend of $0.26

BlackRock Health Sciences Trust (NYSE:BME) declared a monthly dividend on Thursday, September 10th. Shareholders of record on Friday, December 11th will be paid a dividend of 0.2621 per share on Tuesday, December 22nd. This represents a c) annualized dividend and a yield of 7.1%. The ex-dividend date is Friday, December 11th.

BlackRock Health Sciences Trust Price Performance

NYSE:BME opened at $44.08 on Friday. The business’s 50-day simple moving average is $44.19 and its two-hundred day simple moving average is $41.49. BlackRock Health Sciences Trust has a 52 week low of $35.95 and a 52 week high of $46.42.

Institutional Investors Weigh In On BlackRock Health Sciences Trust

A number of institutional investors have recently added to or reduced their stakes in the stock. Northwestern Mutual Wealth Management Co. grew its holdings in BlackRock Health Sciences Trust by 285,436.7% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 4,046,055 shares of the company’s stock valued at $166,414,000 after buying an additional 4,044,638 shares in the last quarter. Bank of America Corp DE bought a new position in shares of BlackRock Health Sciences Trust during the 2nd quarter valued at approximately $11,827,000. 1607 Capital Partners LLC boosted its position in shares of BlackRock Health Sciences Trust by 49.5% during the 4th quarter. 1607 Capital Partners LLC now owns 229,260 shares of the company’s stock valued at $9,429,000 after acquiring an additional 75,958 shares during the last quarter. Royal Bank of Canada grew its holdings in shares of BlackRock Health Sciences Trust by 13.0% in the fourth quarter. Royal Bank of Canada now owns 160,464 shares of the company’s stock valued at $6,600,000 after purchasing an additional 18,442 shares in the last quarter. Finally, Invesco Ltd. increased its position in BlackRock Health Sciences Trust by 7.6% in the third quarter. Invesco Ltd. now owns 217,169 shares of the company’s stock worth $8,085,000 after purchasing an additional 15,381 shares during the last quarter.

About BlackRock Health Sciences Trust

BlackRock Health Sciences Trust (NYSE: BME) is a closed-end management investment company that seeks long-term total return through a combination of dividend income and capital appreciation. Managed by BlackRock Fund Advisors, the trust invests primarily in the equity securities of domestic and international issuers engaged in the health sciences sector. The portfolio typically includes common stocks, corporate bonds and convertible securities of companies involved in biotechnology, pharmaceuticals, medical devices and healthcare services.